(Q45200507)

10 December 2017

title

11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension (English)

1 reference

10 December 2017

1 reference

Nicola Glorioso

1

1 reference

10 December 2017

Fabiana Filigheddu

2

1 reference

10 December 2017

Paolo Pinna Parpaglia

3

1 reference

10 December 2017

Aldo Soro

4

1 reference

10 December 2017

Chiara Troffa

5

1 reference

10 December 2017

Giuseppe Argiolas

6

1 reference

10 December 2017

Paolo Mulatero

7

1 reference

10 December 2017

publication date

15 December 2004

1 reference

10 December 2017

published in

European Heart Journal

1 reference

10 December 2017

volume

26

1 reference

10 December 2017

issue

5

1 reference

10 December 2017

page(s)

498-504

1 reference

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

A Syndrome of Apparent Mineralocorticoid Excess Associated with Defects in the Peripheral Metabolism of Cortisol*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Structural remodeling in hypertensive heart disease and the role of hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Arterial pressure, left ventricular mass, and aldosterone in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary aldosteronism and essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Asymmetric left ventricular remodeling due to isolated septal thickening in patients with systemic hypertension and normal left ventricular masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Power and sample size calculations for studies involving linear regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Left ventricular structural and functional characteristics in Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Serum aldosterone and the incidence of hypertension in nonhypertensive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI070

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHI070

1 reference

10 December 2017

1 reference